Published in J Exp Med on January 01, 1990
Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med (1993) 1.67
Cross-species bone marrow transplantation: evidence for tolerance induction, stem cell engraftment, and maturation of T lymphocytes in a xenogeneic stromal environment (rat----mouse). J Exp Med (1991) 1.46
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med (1993) 1.44
The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS One (2008) 1.29
Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology (1991) 1.13
The marginating-pulmonary immune compartment in rats: characteristics of continuous inflammation and activated NK cells. J Immunother (2010) 0.94
Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins. Brain Behav Immun (2008) 0.92
Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells. Br J Cancer (1996) 0.92
CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis. Clin Exp Immunol (2015) 0.89
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med (1990) 0.83
A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells. J Exp Med (1995) 0.82
NK cell depletion delays corneal allograft rejection in baby rats. Mol Vis (2010) 0.80
Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications. Br J Cancer (2000) 0.80
Structural and functional aspects of the liver and liver sinusoidal cells in relation to colon carcinoma metastasis. World J Gastroenterol (2005) 0.79
An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis. Clin Exp Metastasis (2007) 0.78
Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J Exp Med (1992) 0.77
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer (1975) 5.91
A transplantable mast-cell neoplasm in the mouse. J Natl Cancer Inst (1957) 4.83
Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med (1985) 3.48
In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol (1981) 3.34
An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15
Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol (1981) 3.05
A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med (1989) 2.85
Heterogeneity of natural killer cells. Annu Rev Immunol (1984) 2.59
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature (1977) 2.39
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med (1989) 2.33
Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med (1986) 2.01
In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71
Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells. J Immunol (1980) 1.68
Cell-mediated immunity to tumor cells. Adv Cancer Res (1974) 1.60
Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol (1981) 1.58
Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med (1986) 1.57
Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol (1985) 1.55
Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol (1981) 1.51
Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer (1982) 1.50
Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J Immunol (1986) 1.28
In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J Immunol (1983) 1.26
Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukoc Biol (1985) 1.23
Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J Exp Med (1984) 1.19
Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes. J Immunol (1987) 1.18
Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines. J Exp Med (1985) 1.07
Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res (1965) 1.04
In vivo reduction of NK activity with anti-NK 1 serum: direct evaluation of NK cells in tumor clearance. Int J Cancer (1982) 0.96
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Natural killer cell number and function in the spontaneously diabetic BB/W rat. J Immunol (1986) 0.94
A cell surface antigen expressed on mouse lung macrophages. Microbiol Immunol (1981) 0.89
Selective expression of asialo GM1 on maturational subsets of lymphocytes in normal and athymic mice. Thymus (1981) 0.81
In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma. Anticancer Res (1989) 0.80
Surface markers on natural killer cells of the mouse. Eur J Immunol (1979) 0.80
Protective role of natural killer cells in tumor growth and viral infection in mice. Exp Cell Biol (1984) 0.80
In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Cancer Res (1986) 0.80
Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity. Nat Immun Cell Growth Regul (1988) 0.79
Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid. Thymus (1981) 0.77
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med (1989) 2.33
NKR-P1, a signal transduction molecule on natural killer cells. Science (1990) 1.94
Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming, and killer cell-independent steps. J Immunol (1982) 1.51
The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes. J Immunol (1988) 1.47
The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol (1978) 1.40
NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium. J Immunol (1991) 1.31
Effects of in vivo treatment with FK506 on natural killer cells in rats. Transplantation (1991) 1.22
Generation and characterization of purified adherent lymphokine-activated killer cells in mice. J Immunol (1989) 1.19
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res (1988) 1.10
The importance of diagnostic accuracy in colonic inflammatory bowel disease. Am J Gastroenterol (2000) 1.07
Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology (2000) 1.01
Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res (1989) 1.00
Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med (1988) 0.98
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol (1996) 0.95
In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells. Cell Immunol (1988) 0.94
Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro. Immunobiology (1999) 0.93
Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas. Am J Pathol (1988) 0.93
Expression of a laminin-like substance on the surface of murine natural killer (NK) lymphocytes and its role in NK recognition of tumor target cells. J Immunol (1985) 0.93
Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis. Am J Ophthalmol (1993) 0.92
Effect of caffeine on maximal strength and power in élite male athletes. Br J Sports Med (1992) 0.91
Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Cancer Res (1988) 0.87
Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. J Immunol (1983) 0.87
In vivo migration and tissue localization of highly purified lymphokine-activated killer cells (A-LAK cells) in tumor-bearing rats. Cell Immunol (1990) 0.87
Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int J Radiat Oncol Biol Phys (1997) 0.86
In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cell Immunol (1976) 0.86
Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res (1988) 0.85
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int J Cancer (1996) 0.84
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J Exp Med (1990) 0.83
In situ localization of 3.2.3+ natural killer cells in tissues from normal and tumor-bearing rats. Cancer Res (1991) 0.83
Reduced natural killer cell activity in patients with systemic sclerosis. Correlation with clinical disease type. Arthritis Rheum (1988) 0.83
Effects of splenectomy on the development of tumor-specific immunity. J Surg Res (1990) 0.81
In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol (1997) 0.81
Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor. J Immunol (1999) 0.81
The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s). Cell Immunol (1979) 0.81
NKR-P1+ cells in the rat uterus: granulated metrial gland cells are of the natural killer cell lineage. Biol Reprod (1994) 0.81
Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro. J Immunol (1977) 0.80
Effects of irradiation on the expression of surface antigens in human ovarian cancer. Gynecol Oncol (1996) 0.80
Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol (1998) 0.80
Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes. Am J Pathol (1985) 0.80
Identification of multiple cytolytic components associated with the beta-LT class of lymphotoxins released by mitogen-activity human lymphocytes in vitro. J Immunol (1976) 0.80
In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Cancer Res (1986) 0.80
Effect of selective depletion of natural killer cells on allograft rejection. Transplant Proc (1991) 0.79
The human lymphotoxin system. J Reticuloendothel Soc (1978) 0.79
Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-alpha. Int J Cancer (1997) 0.79
The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cells from several animal species. J Immunol (1979) 0.79
Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol (1997) 0.79
Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells. Cell Immunol (1989) 0.79
Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. J Immunol (1988) 0.79
Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation. J Immunol (1988) 0.78
The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol (1998) 0.78
Development and characterization of an IL-4-secreting human ovarian carcinoma cell line. Gynecol Oncol (1995) 0.78
Identification of membrane-associated lymphotoxin (LT) on mitogen-activated human lymphocytes using heterologous anti-LT antisera in vitro. Cell Immunol (1977) 0.78
Inhibition of human natural killing by heterologous and monoclonal antibodies. J Immunol (1982) 0.78
In vivo induced allo-reactive natural killer cells. J Immunol (1992) 0.77
Mother-infant separation in group-living rhesus macaques: a hormonal analysis. Dev Psychobiol (1979) 0.77
Studies on the mechanism of the human natural killer cell lethal hit: evidence for transfer of protease-sensitive structures requisite for target cell lysis. J Immunol (1983) 0.77
CD8+ T-cells are required for adoptive transfer of the BB rat diabetic syndrome. Diabetes (1993) 0.77
The role of NK cell activity in the pathogenesis of poly I:C accelerated and spontaneous diabetes in the diabetes prone BB rat. J Autoimmun (1995) 0.77
Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J Exp Med (1992) 0.77
The human LT system. IV. Studies on the large MW LT complex class: association of these molecules with specific antigen binding receptor(s) in vitro. Cell Immunol (1978) 0.77
In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes. Cell Immunol (1976) 0.77
The human LT system. III. Characterization of a high molecular weight LT class (complex) composed of the various smaller MW LT classes and subclasses in association with Ig-like molecules. Cell Immunol (1978) 0.76
Distribution of lymphocyte subsets in rat milk from normal and Trichinella spiralis-infected rats. J Reprod Immunol (1992) 0.75
Differential effects of high-dose gamma irradiation on the production of transforming growth factor-beta in fresh and established human ovarian cancer. Gynecol Oncol (1996) 0.75
Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer (1998) 0.75
Lysis of NK target cells by soluble cytotoxic factor(s) and inhibition by a xenoantiserum directed against cytotoxic cells. Transplant Proc (1981) 0.75
The cytotoxic action of OK-432 from Streptococcus pyogenes. Med Hypotheses (1990) 0.75
Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules. Am J Obstet Gynecol (1996) 0.75
Mechanisms of target cell killing by natural killer cells. Curr Opin Immunol (1989) 0.75
Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms. Bone Marrow Transplant (1990) 0.75
Studies on the induction and expression of T-cell-mediated immunity. XIII. Membrane-associated antigens of cytotoxic T lymphocytes involved in cytotoxicity. Cell Immunol (1983) 0.75
Adoptive immunotherapy of murine mammary carcinoma using broadly cytotoxic cloned T lymphocytes. Prog Clin Biol Res (1987) 0.75
Identification and partial characterization of a novel plasma membrane-associated lytic factor isolated from highly purified adherent lymphokine-activated killer cells. Cell Immunol (1992) 0.75
Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat. Blood (1991) 0.75
Lymphokine-activated killer cell purging of leukemia cells from bone marrow prior to syngeneic transplantation. Transplantation (1988) 0.75
T-cell membrane antigens associated with cytotoxic function. Immunol Today (1982) 0.75
Is there evidence for transfer of materials from the killer cell to the target requisite for target cell lysis? Ann Inst Pasteur Immunol (1987) 0.75
A "nonidiotypic" inhibition of influenza-immune H-2-restricted CTL by an anti-T cell serum. J Immunol (1980) 0.75
Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes. J Immunol (1982) 0.75
Stimuli from pups of adrenalectomized and malnourished female rats. Physiol Behav (1978) 0.75
Laminin production by murine melanoma cells: possible involvement in cell motility. Clin Exp Metastasis (1987) 0.75
The importance of splenectomy for the adoptive immunotherapy of cancer. Med Hypotheses (1989) 0.75
Laminin receptor expression on murine tumor cells: correlation with sensitivity to natural cell-mediated cytotoxicity. Int J Cancer (1989) 0.75
A unified theory for the mechanism of the lethal hit by cytotoxic T lymphocytes (CTL) and natural killer (NK) cells as defined by antisera capable of blocking the lethal hit stage of cytotoxicity. Adv Exp Med Biol (1985) 0.75
Natural cell-mediated immunity in the rabbit. Cell Immunol (1990) 0.75
The human LT system. II. Immunological relationships of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol (1978) 0.75
The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes. Cell Immunol (1979) 0.75